Baillie Gifford & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Baillie Gifford & Co’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-283	Closed	-$11.1K	–	443
2023 Q1	$11.1K	Buy	283 +48	+20%	+$2.35K	﹤0.01%	391
2022 Q4	$12.4K	Hold	235	–	–	﹤0.01%	396
2022 Q3	$11K	Hold	235	–	–	﹤0.01%	410
2022 Q2	$9K	Hold	235	–	–	﹤0.01%	426
2022 Q1	$10K	Hold	235	–	–	﹤0.01%	437
2021 Q4	$10K	Hold	235	–	–	﹤0.01%	450
2021 Q3	$13K	Hold	235	–	–	﹤0.01%	427
2021 Q2	$11K	Hold	235	–	–	﹤0.01%	428
2021 Q1	$12K	Buy	235 +2	+0.9%	+$111	﹤0.01%	392
2020 Q4	$15K	Buy	+233	New	+$14.5K	﹤0.01%	355

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Baillie Gifford & Co's SILK Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 283 shares — an estimated $11.1K sold.

Baillie Gifford & Co first reported a position in SILK in Q4 2020 and held it in 10 quarters. The position peaked at $15K in Q4 2020. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

Baillie Gifford & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Baillie Gifford & Co sold 283 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $11.1K.
Baillie Gifford & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
Baillie Gifford & Co's Silk Road Medical, Inc. Common Stock position peaked at $15K in Q4 2020.
173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.